Clinical effect of dopamine on incidence of peptic ulceration.
Dopamine and its agonists diminish gastric acid secretion and exert a protective effect on experimentally induced peptic ulcers in rats. For treatment of peptic ulcer disease in man, dopamine and dopamine antagonists have been recommended, but clear evidence is not yet available. To answer the question of whether dopamine has any protective effect regarding peptic ulcer formation in man, autopsy reports were evaluated for the incidence of acute peptic ulcerations before and after the introduction of dopamine as a common drug in intensive care units. The analysis showed no change in ulcer incidence, i.e., our retrospective study demonstrated no ulceroprotective action of dopamine in critically ill patients.
D004298:Dopamine / Q000627:therapeutic use*; D005756:Gastritis / Q000209:etiology; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D006801:Humans; D010437:Peptic Ulcer / Q000209:etiology*; D011954:Receptors, Dopamine / Q000187:drug effects; D013312:Stress, Physiological / Q000150:complications; D013727:Terminal Care
D006635:Histamine H2 Antagonists; D011954:Receptors, Dopamine; D004298:Dopamine